Evidence map›Paper›PMID 35628032›Full record

ArticleHealthcare (Basel, Switzerland)2022

High Incidence Rate of SARS-CoV-2 Infection in Health Care Workers at a Dedicated COVID-19 Hospital: Experiences of the Pandemic from a Large Mexican Hospital.

Nallely Bueno-Hernández, José Damian Carrillo-Ruíz, Lucía A Méndez-García, Salma A Rizo-Téllez, Rebeca Viurcos-Sanabria, Alisson Santoyo-Chávez, René Márquez-Franco, Alejandro Aguado-García, Neyla Baltazar-López, Yoshio Tomita-Cruz and 11 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nallely Bueno-HernándezLaboratory of Proteomics, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.ORCID 0000-0002-3961-0987
José Damian Carrillo-RuízResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Lucía A Méndez-GarcíaLaboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.ORCID 0000-0001-7576-5209
Salma A Rizo-TéllezLaboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.ORCID 0000-0003-0587-5167
Rebeca Viurcos-SanabriaLaboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Alisson Santoyo-ChávezLaboratory of Proteomics, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
René Márquez-FrancoResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Alejandro Aguado-GarcíaResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Neyla Baltazar-LópezResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Yoshio Tomita-CruzResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Eira Valeria BarrónUnidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Ana Laura SánchezUnidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.ORCID 0000-0002-9478-4779
Edna MárquezUnidad de Medicina Genómica, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Ruben FossionInstituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0001-8456-2075
Ana Leonor RiveraInstituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-0296-7966
Luis RuelasCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Octavio A LeconaCentro de Ciencias de la Complejidad (C3), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Gustavo Martínez-MeklerInstituto de Ciencias Físicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Markus MüllerInstituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
América G Arroyo-ValerioResearch Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
Galileo EscobedoLaboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.ORCID 0000-0002-9224-7400

Funding

Consejo Nacional de Ciencia y Tecnología 312512
6 · The paper itself

Abstract

Health care workers (HCW) are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The incidence of SARS-CoV-2 infection in HCW has been examined in cross-sectional studies by quantitative polymerase chain reaction (qPCR) tests, which may lead to underestimating exact incidence rates. We thus investigated the incidence of SARS-CoV-2 infection in a group of HCW at a dedicated coronavirus disease 2019 (COVID-19) hospital in a six-month follow-up period. We conducted a prospective cohort study on 109 participants of both sexes working in areas of high, moderate, and low SARS-CoV-2 exposure. qPCR tests in nasopharyngeal swabs and anti-SARS-CoV-2 IgG serum antibodies were assessed at the beginning and six months later. Demographic, clinical, and laboratory parameters were analyzed according to IgG seropositivity by paired Student's T-test or the chi-square test. The incidence rate of SARS-CoV-2 infection was considerably high in our cohort of HCW (58%), among whom 67% were asymptomatic carriers. No baseline risk factors contributed to the infection rate, including the workplace. It is still necessary to increase hospital safety procedures to prevent virus transmissibility from HCW to relatives and non-COVID-19 patients during the upcoming waves of contagion.

Indexed as

COVID-19health care workersIgG antibodyincidence of infectionpandemicSARS-CoV-2

Identifiers

PMID35628032
PMCPMC9141357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.